Blog
Patient’s Corner: Living with Chronic Illness Vol. 2
By Dorothy Leone-Glasser I met Mapillar Dahn and the MTS Sickle Cell Foundation, Inc. at our Rx in Reach GA Coalition Capitol Day. She was excited to participate in our event and had a table set to distribute Sickle Cell Awareness material and to engage visitors, attendees and legislators on the challenges of living with…
Read MoreUntangling the Intricate World of Digital Health Regulation-The HSB Blog 6/28/21
Our Take: The current regulatory landscape for digital health tools is complex and doesn’t lend itself to easily determining where digital health tools belong or how they should be regulated. As a result it is not clear how to design these tools within regulatory guidelines and what process they should or may need to follow…
Read MoreVaccines could make big Ebola outbreaks a thing of the past
With approved vaccines and better health-care systems, 2 recent outbreaks in Africa have been managed quickly and with few deaths The era of large and deadly Ebola outbreaks may soon be over, thanks in part to vaccines and improvements in health-care delivery. After lengthy Ebola virus disease outbreaks claimed thousands of lives in both West…
Read MoreHow one medical team is bringing COVID-19 vaccines to hard-to-reach Hispanic communities
Unidos Contra COVID totes shots, empathy and facts to Philadelphia’s Spanish-speaking residents In a makeshift tent behind a soccer goal and close enough to a taco stand that the smell of grilling barbacoa and carnitas drifts over, Melissa Pluguez cheerfully asks a man, in Spanish, if he’s right- or left-handed. The man, wearing jeans and…
Read More‘Nobody is catching it’: Algorithms used in health care nationwide are rife with bias
The algorithms carry out an array of crucial tasks: helping emergency rooms nationwide triage patients, predicting who will develop diabetes, and flagging patients who need more help to manage their medical conditions. But instead of making health care delivery more objective and precise, a new report finds, these algorithms — some of which have been in…
Read MoreWhy we need to simulate the entire U.S. health system
Facebook unveiled a remarkable piece of internal infrastructure in the spring of 2020. Called Web-Enabled Simulation (WES), the platform is a detailed replica of Facebook, with artificial user accounts ranging from simple bots that browse the site to machine-learning-based agents that mimic social interactions. The sophistication of the platform is astonishing. Going far beyond traditional realms of…
Read MoreModels predict U.S. coronavirus infections could surge this fall if vaccination rates lag, former FDA chief says
Scott Gottlieb also expressed concern about U.K. study showing brain-tissue shrinkage after covid-19 The transmission of the more contagious delta variant in the United States could spur a fall surge in coronavirus infections if only 75 percent of the country’s eligible population is vaccinated, former Food and Drug Administration chief Scott Gottlieb said Sunday. Although Gottlieb cited…
Read MoreAfter racing to help the world understand Covid-19, scientists grapple with how to pick up the research they put on hold
In the earliest days of the pandemic, it was the small, long-underfunded coterie of dedicated coronavirus researchers answering almost all of the world’s questions about the emerging threat. But as SARS-CoV-2 took off, researchers from other specialties flooded in, drawn by the scale of the emergency, a desire to put their skills to use, and the competitive…
Read MoreStudy shows potential dangers of sweeteners
New research: Sweeteners could cause gut bacteria to invade the intestine New research has discovered that common artificial sweeteners can cause previously healthy gut bacteria to become diseased and invade the gut wall, potentially leading to serious health issues. The study, published in the International Journal of Molecular Sciences, is the first to show the pathogenic effects…
Read MoreThe Only Way We’ll Know When We Need COVID-19 Boosters
Research can tell us only so much. The rest is a waiting game. Midway through America’s first mass-immunization campaign against the coronavirus, experts are already girding themselves for the next. The speedy rollout of wildly effective shots in countries such as the United States, where more than half the population has received at least one…
Read More